Literature DB >> 30430190

[Brain stimulation for the selective treatment of schizophrenia symptom domains : Non-invasive and invasive concepts].

Thomas M Kinfe1, René Hurlemann2.   

Abstract

Given that one third of patients with schizophrenia (SZ) only show limited response to established treatments, alternative therapeutic strategies such as non-invasive/invasive brain stimulation approaches have emerged as an adjunctive treatment option for distinct SZ symptom domains (e.g. acoustic hallucinations, negative/positive symptoms and cognitive impairment). Taking comparative interventional studies and standardized technical parameters into consideration, current meta-analyses indicate that adjunctive electroconvulsive therapy, repetitive transcranial magnetic stimulation and transcranial direct current stimulation have a positive effect. Invasive deep brain stimulation and MR-guided ultrasound brain ablation procedures represent treatment modalities that are currently being clinically tested. Complementary pre-interventional screening approaches (e.g. electrophysiology, neuroimaging and molecular inflammatory profiling) have been recommended in order to identify symptom-tailored predictive measures for diagnosis and treatment.

Entities:  

Keywords:  Electroconvulsive therapy; Personalized, predictive brain stimulation; Repetitive transcranial magnetic stimulation; Stereotactic, deep brain modulation; Transcranial direct current/alternating current stimulation

Mesh:

Year:  2019        PMID: 30430190     DOI: 10.1007/s00115-018-0640-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  1 in total

Review 1.  [Transcranial electrical brain stimulation methods for treatment of negative symptoms in schizophrenia].

Authors:  Nikolas Haller; Alkomiet Hasan; Frank Padberg; Wolfgang Strube; Leandro da Costa Lane Valiengo; Andre R Brunoni; Jerome Brunelin; Ulrich Palm
Journal:  Nervenarzt       Date:  2021-01-25       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.